Join the club for FREE to access the whole archive and other member benefits.
Key points from article :
Insilico Medicine applying big data analytics to extend healthy longevity.
pursuing internal drug discovery in cancer, Parkinson’s, Alzheimer’s, sarcopenia and in geroprotectors.
Investment will fund validation of the many molecules discovered using machine learning.
Company has published studies including minute changes in gene expression between young and old tissues.
Click on resource name for more details.
CEO of InSilico Medicine & Deep Longevity. CSO of Biogerontology Research Foundation
Biotechnology company that uses artificial intelligence to develop new drugs and for aging research
British entrepreneur, author and philanthropist with interests across a number of industries
The book written by Jim Mellon & Al Chalabi investigates the new technologies and explains how to benefit from the life extending technologies
